You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

  • Technology appraisal guidance
  • Reference number: TA333
  • Published:  25 February 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Renal cell carcinoma (advanced) - axitinib [ID518]: final appraisal determination document

Renal cell carcinoma (advanced) - axitinib [ID518]: final appraisal determination document Renal cell carcinoma (advanced) - axitinib [ID518]: final appraisal determination document
16 December 2014
(628.11 Kb 2 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 11 December 2014

Back to top